Branded Legacy, Inc. (OTC: BLEG), a dynamic diversified holdings company at the forefront of health and wellness innovation, is excited to announce the completion of its game-changing acquisition of Bio Legacy Evaluative Group, formerly Menlo Health (“Bio Legacy”). This strategic move, executed under an Acquisition Agreement dated July 28, 2025, propels Branded Legacy into the lucrative biotech and medical device arenas, targeting urgent global health challenges like the addiction epidemic and vaccine distribution inefficiencies. Bio Legacy’s revolutionary patented all-in-one intranasal naloxone device tackles the addictions crisis head-on by slashing costs, boosting dosing accuracy, and simplifying delivery.
Read the full article: Branded Legacy, Inc. Finalizes Transformative Acquisition of Bio Legacy Evaluative Group (f/k/a Menlo Health) //
Source: https://www.globenewswire.com/news-release/2025/08/12/3131684/0/en/Branded-Legacy-Inc-Finalizes-Transformative-Acquisition-of-Bio-Legacy-Evaluative-Group-f-k-a-Menlo-Health-Unlocking-Explosive-Growth-Potential-in-Biotech-and-Drug-Delivery.html